FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients

Journal of Medical Genetics

Volumn 41, Issue 11, 2004, Pages 826-836

  Rijkers, T ^a,f   Deidda, G ^a,f   Van Koningsbruggen, S ^a   Van Geel, M ^b   Lemmers, R J L F ^a   Van Deutekom, J C T ^a   Figlewicz, D ^c   Hewitt, J E ^d   Padberg, G W ^e   Frants, R R ^a   Van Der Maarel, S M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MYOD PROTEIN;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 10; CHROMOSOME 4; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FIBROBLAST; FLUORESCENCE IN SITU HYBRIDIZATION; FSHD REGION GENE 2; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INCIDENCE; MULTIGENE FAMILY; MUSCLE DEVELOPMENT; MYOBLAST; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MYOBLASTS, SKELETAL; PROMOTER REGIONS (GENETICS); PROTEINS; TRANS-ACTIVATION (GENETICS); UP-REGULATION;

EID: 8744240156     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2004.019364     Document Type: Article

References (53)

1. Funakoshi M, Goto K, Arahata K. Epilepsy and mental retardation in a subset of early onset 4q35-facioscapulohumeral muscular dystrophy. Neurology 1998;50(6):1791-4.
2. Padberg GW. Facioscapulohumeral disease [thesis]. Leiden: Leiden University, 1982.
3. Padberg GW, Frants RR, Brouwer OF, Wijmenga C, Bakker E, Sandkuijl LA. Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve 1995;2:S81-4.
4. Sarfarazi M, Wijmenga C, Upadhyaya M, Weiffenbach B, Hyser C, Mathews K, Murray J, Gilbert J, Pericak Vance M, Lunt P, Frants RR, Jacobsen S, Harper PS, Padberg GW. Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. Am J Hum Genet 1992;51(2):396-403.
5. Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber JL, Padberg GW. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 1990;336(8716):651-3.
6. Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, Dauwerse HG, Gruter AM, Hofker MH, Moerer P, Williamson R, van Ommen GJ, Padberg GW, Frants RR. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992;2(1):26-30.
7. Van Deutekom JC, Wijmenga C, van Tienhoven EA, Gruter AM, Hewitt JE, Padberg GW, van Ommen GJ, Hofker MH, Frants RR. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 1993;2(12):2037-42.
8. Hewitt JE, Lyle R, Clark LN, Valleley EM, Wright TJ, Wijmenga C, van Deutekom JC, Francis F, Sharpe PT, Hofker M, Frants RR, Williamson R. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 1994;3(8):1287-95.
9. Lee JH, Gota K, Matsuda C, Arahata K. Characterization of a tandemly repeated 3.3-kb Kpnl unit in the facioscapulohumeral muscular dystrophy (FSHD) gene region on chromosome 4q35. Muscle Nerve 1995;2:6-13.
10. Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet 1995;4(5):951-8.
11. Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neural 1996;39(6):744-8.
12. Winokur ST, Bengtsson U, Feddersen J, Mathews KD, Weiffenboch B, Bailey H, Markovich RP, Murray JC, Wasmuth JJ, Altherr MR, Schutte BC. The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease. Chromosome Res 1994;2(3):225-34.
13. Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der MS, Ehrlich M. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 2003;12(22):2909-21.
14. Winokur ST, Chen YW, Masny PS, Martin JH, Ehmsen JT, Tapscott SJ, van der Maarel SM, Hayashi Y, Flanigan KM. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet 2003;12(22):2895-907.
15. Stout K, van der Maarel S, Frants RR, Padberg GW, Ropers H-H, Haaf T. Somatic pairing between subtelomeric regions: implications for human genetic disease? Chromosome Res 1999;7:323-9.
16. Van der Maarel SM, Deidda G, Lemmers RJ, van Overveld PG, van der Wielen M, Hewitt JE, Sandkuijl L, Bakker B, van Ommen GJ, Padberg GW, Fronts RR. De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10. Am J Hum Genet 2000;66(1):26-35.
17. Lemmers RJ, van Overveld PG, Sandkuijl LA, Vrieling H, Padberg GW, Frants RR, van der Maarel SM. Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy. Am J Hum Genet 2004;75(1):44-53.
18. Van Overveld PG, Lemmers RJ, Sandkuijl LA, Enthoven L, Winokur ST, Bakels F, Padberg GW, van Ommen GJ, Frants RR, van der Maarel SM. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 2003;35(4):315-7.
19. Gabellini D, Green M, Tupler R. Inappropriate gene activation in FSHD. A represser complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 2002;110(3):339-48.
20. Gabriels J, Beckers MC, Ding H, De Vriese A, Plaisance S, van der Maarel SM, Padberg GW, Frants RR, Hewitt JE, Collen D, Belayew A. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 1999;236(1):25-32.
21. Yip DJ, Picketts DJ. Increasing D4Z4 repeat copy number compromises C2C12 myoblast differentiation. FEBS Lett 2003;537(1-3):133-8.
22. Bakker E, Wijmenga C, Vossen RH, Padberg GW, Hewitt J, van der Wielen M, Rasmussen K, Frants RR. The FSHD-linked locus D4F104S1 (p13E11) on 4q35 has a homologue on 10qter. Muscle Nerve 1995;2:39-44.
23. Deidda G, Cacurri S, Grisanti P, Vigneti E, Piazzo N, Felicetti L. Physical mapping evidence far a duplicated region on chromosome 10qter showing high homology with the facioscapulohumeral muscular dystrophy locus on chromosome 4qter. Eur J Hum Genet 1995;3:155-67.
24. Van Deutekom K, Bakker E, Lemmers RJ, van der Wielen MJ, Bik E, Hofker MH, Padberg GW, Frants RR. Evidence far subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications far genetic counselling and etiology of FSHD1. Hum Mol Genet 1996;5(12):1997-2003.
25. Van Overveld PG, Lemmers RJ, Deidda G, Sandkuijl L, Padberg GW, Frants RR, van der Maarel SM. Interchromosomal repeat array interactions between chromosomes 4 and 10: a model far subtelomeric plasticity. Hum Mol Genet 2000;9(19):2879-84.
26. Lemmers RJL, de Kievit P, van Geel M, van der Wielen MJ, Bakker E, Padberg GW, Frants RR, van der Maarel SM. Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis. Ann Neurol 2001;50(6):816-9.
27. Zhang Y, Forner J, Fournet S, Jeanpierre M. Improved characterization of FSHD mutations. Ann Genet 2001;44(2):105-10.
28. Van Geel M, van Deutekom JC, van Stoalduinen A, Lemmers RJ, Dickson MC, Hofker MH, Padberg GW, Hewitt JE, de Jong PJ, Frants RR. Identification of a novel beta-tubulin subfamily with one member (TUBB4Q) located near the telomere of chromosome region 4q35. Cytogenet Cell Genet 2000;88(3-4):316-21.
29. Van Koningsbruggen S, Dirks RW, Mommaas AM, Underwater J, Deidda G, Padberg GW, Frants RR, van der Maarel SM. FRG1P is localized in the nudeolus, Cajal bodies and speckles. J Med Genet 2004;41:e46.
30. Grewal PK, Carim Todd L, van der Maarel S, Frants RR, Hewitt JE. FRG1, a gene in the FSH muscular dystrophy region on human chromosome 4q35, is highly conserved in vertebrates and invertebrates. Gene 1998;216:13-9.
31. Van Deutekom JCT, Lemmers RJLF, Grewal PK, van Geel M, Romberg S, Dauwerse HG, Wright TJ, Padberg GW, Hofker MH, Hewitt JE, Frants RR. Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35. Hum Mol Genet 1996;5(5):581-90.
32. Van Geel M, Heather U, Lyle R, Hewitt JE, Frants RR, de Jong PJ. The FSHD region on human chromosome 4q35 contains potential coding regions among pseudogenes and a high density of repeat elements. Genomics 1999;61(1):55-65.
33. Shoubridge EA, Johns T, Baulet L. Use of myoblast cultures to study mitochondrial myopathies. Methods Enzymol 1996;264:465-75.
34. Murry CE, Kay MA, Bartosek T, Hauschka SD, Schwartz SM. Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. J Clin Invest 1996;98(10):2209-17.
35. Roest PA, Bakker E, Fallaux FJ, Verellen-Dumoulin C, Murry CE, den Dunnen JT. New possibilities for prenatal diagnosis of muscular dystrophies: forced myogenesis with an adenoviral MyoD-vector. Lancet 1999;353(9154):727-8.
36. Georgiev O, Bourquin JP, Gstaiger M, Knoepfel L, Schaffner W, Hovens C. Two versatile eukaryotic vectors permitting epitope togging, radiolabelling and nuclear localisation of expressed proteins. Gene 1996;168(2):165-7.
37. Cuppen E, Gerrits H, Pepers B, Wieringa B, Hendriks W. PDZ motifs in PTP-BL and RIL bind to internal protein segments in the UM domain protein RIL. Mol Biol Cell 1998;9(3):671-83.
38. Langer PR, Waldrop AA, Ward DC. Enzymatic synthesis of biotin labelled polynucleotides: novel nucleic acid affinity probes. Proc Natl Acad Sci U S A 1981;78:6633-7.
39. Dauwerse JG, Jumelet EA, Wessels JW, Saris JJ, Hagemeijer A, Beverstock GC, van Ommen GJ, Breuning MH. Extensive cross-homology between the long and the short arm of chromosome 16 may explain leukemic inversions and translocations. Blood 1992;79(5):1299-304.
40. Gauld SJ, Keller GA, Hosken N, Wilkinson J, Subramani S. A conserved tripeptide sorts proteins to peroxisomes. J Cell Biol 1989;108(5):1657-64.
41. Swinkels BW, Gould SJ, Subramani S. Targeting efficiencies of various permutations of the consensus C-terminal tripeptide peroxisomal targeting signal. FEBS Lett 1992;305(2):133-6.
42. Van Geel M, Eichler EE, Beck AF, Shan Z, Haaf T, van der Maarel SM, Frants RR, de Jong PJ. A cascade of complex subtelomeric duplications during the evolution of the hominoid and old world monkey genomes. Am J Hum Genet 2002;70(1):269-78.
43. Mefford HC, Trask BJ. The complex structure and dynamic evolution of human subtelomeres. Nat Rev Genet 2002;3(2):91-102.
44. Winokur ST, Barrett K, Martin JH, Forrester JR, Simon M, Tawil R, Chung SA, Masny PS, Figlewicz DA. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul Disord 2003;13(4):322-33.
45. Figlewicz DA, Barrett K, Leskovar AH, Forrester JR, Sawden JE, Tawil R. FSHD myoblasts: in vitro studies. In: Upadhyaya M, Cooper DN, eds. Facioscapulohumeral muscular dystrophy: clinical medicine and molecular cell biology. Oxon, UK: Garland Science/BIOS scientific publishers, 2004:235-51.
46. Hettema EH, Distel B, Tabak HF. Import of proteins into peroxisomes. Biochim Biophys Acta 1999;1451(1):17-34.
47. Trask BJ, Friedman C, Martin-Gallardo A, Rowen L, Akinbami C, Blankenship J, Collins C, Giorgi D, Iadonato S, Johnson F, Kuo WL, Massa H, Morrish T, Naylor S, Nguyen OT, Rouquier S, Smith T, Wong DJ, Youngblom J, van den Engh G. Members of the olfactory receptor gene family are contained in large blocks of DNA duplicated polymorphically near the ends of human chromosomes. Hum Mol Genet 1998;7(1):13-26.
48. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A 1989;86(14):5434-8.
49. Gerber AN, Klesert TR, Bergstrom DA, Tapscott SJ. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev 1997;11(4):436-50.
50. Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der MS, Ehrlich M. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 2003;12(22):2909-21.
51. Pirrotta V. Transvection and chromosomal trans-interaction effects. Biochim Biophys Acta 1999;1424(1):1-8.
52. Van Geel M, Dickson MC, Beck AF, Bolland DJ, Frants RR, van der Maarel SM, de Jong PJ, Hewitt JE. Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. Genomics 2002;79(2):210-7.
53. Lemmers RJ, Osborn M, Haaf T, Rogers M, Frants RR, Padberg GW, Cooper DN, van der Maarel SM, Upadhyaya M. D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection. Neurology 2003;61(2):178-83.